Bupenorphine / Naloxone : SMB’s product is proposed as a fixed dose combination in sublingual tablet for oral administration and in strengths of 8/2mg or 2/0.5mg.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy Policy
